Crystalvue Medical Co (ROCO:6527) LT-Debt-to-Total-Asset: 0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6527 Crystalvue Medical Co Ltd ROCO:6527
94 GF Score
Price NT$71.00
GF Value NT$95.39
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Crystalvue Medical Co LT-Debt-to-Total-Asset?

Crystalvue Medical Co ROCO:6527 -0.28% 94 LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus rates ROCO:6527 with a GF Score™ of 94/100 and a GF Value™ of NT$95.39 (Modestly Undervalued). The stock has 1 warning sign investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Crystalvue Medical Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.00.

Crystalvue Medical Co's long-term debt to total assets ratio declined from Dec. 2024 (0.01) to Dec. 2025 (0.00). It may suggest that Crystalvue Medical Co is progressively becoming less dependent on debt to grow their business.

Crystalvue Medical Co  (ROCO:6527) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Crystalvue Medical Co LT-Debt-to-Total-Asset Related Terms

Crystalvue Medical Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Crystalvue Medical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crystalvue Medical Co LT-Debt-to-Total-Asset Chart

Crystalvue Medical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.03 0.02 0.01 0.00

Crystalvue Medical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.00
ROCO:6527
94GF Score
Crystalvue Medical Co Ltd ROCO:6527
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crystalvue Medical Co LT-Debt-to-Total-Asset Calculation

Crystalvue Medical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=4.749/1295.28
=0.00

Crystalvue Medical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=4.749/1295.28
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Crystalvue Medical Co (ROCO:6527) has a LT-Debt-to-Total-Asset of 0.00 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Crystalvue Medical Co and its competitors.
Is Crystalvue Medical Co's LT-Debt-to-Total-Asset too high?
Crystalvue Medical Co's current LT-Debt-to-Total-Asset is 0.00. Overall, Crystalvue Medical Co has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crystalvue Medical Co's LT-Debt-to-Total-Asset compare to ISRG and BDX?
Crystalvue Medical Co's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Medical Devices & Instruments company?
A good LT-Debt-to-Total-Asset depends on the Medical Devices & Instruments industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Crystalvue Medical Co and its competitors. Crystalvue Medical Co's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crystalvue Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Crystalvue Medical Co (ROCO:6527) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$95.39, compared to a current price of NT$71.00 — trading 25.6% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Crystalvue Medical Co's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Crystalvue Medical Co (ROCO:6527), the current LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crystalvue Medical Co (ROCO:6527) Overvalued in 2026?

Based on GuruFocus' analysis, Crystalvue Medical Co stock appears to be undervalued. The current stock price of NT$71.00 is trading 25.6% below its estimated GF Value™ of NT$95.39. GuruFocus considers Crystalvue Medical Co to be Modestly Undervalued.

Key valuation signals for ROCO:6527:

  • LT-Debt-to-Total-Asset: 0.00
  • GF Value™: NT$95.39 vs. price of NT$71.00 (25.6% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6527 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crystalvue Medical Co Business Description

Address No. 116, Lane 956, Zhongshan Road, Taoyuan District, Taoyuan, TWN, 33072
Crystalvue Medical Co Ltd is engaged in the manufacture and sale of medical devices. Its products include fundus cameras, optical coherence tomography (OCT) systems, tonometers, digital microscope cameras, lens edgers, and gastrointestinal endoscopic disposable devices, among others.
94GF Score

Get the complete analysis for ROCO:6527

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.00
Price
NT$95.39
GF Value